| 引用本文: | 徐森敖,周玉平,周霞,曾红霞.盐酸洛美沙星滴耳液中洛美沙星与辅料反应杂质研究[J].中国现代应用药学,2026,43(18):146-153. |
| xu sen ao,zhou yu ping,zhou xia,zeng hong xia.Study on the Reaction Impurity Between Lomefloxacin and Excipient in Lomefloxacin Hydrochloride Ear Drops[J].Chin J Mod Appl Pharm(中国现代应用药学),2026,43(18):146-153. |
|
| 摘要: |
| 目的 对盐酸洛美沙星滴耳液中未知杂质进行结构鉴定、分析产生原因,并建立新方法进行控制。方法 通过液相色谱-离子肼-飞行时间高分辨质谱联用技术(LC/IT-TOF MS)分离鉴定未知杂质的结构,采用稳定性试验研究国内6厂家不同处方工艺的产品,分析杂质产生机制,并对杂质分析方法进行验证。结果 确证该杂质为在温度较高的条件下,处方中的辅料甘油与洛美沙星哌嗪环上的碳氮键脱水缩合生成的杂质;新建立的HPLC分析方法专属性强、精密度、准确性、线性和耐用性均良好。结论 本研究对制剂研究中的部分未知杂质的控制有一定的指导意义,提示国内部分企业应关注原料药与辅料相容性问题。 |
| 关键词: 盐酸洛美沙星 杂质解析 未知杂质 LC-IT-TOF/MS 原辅料相容 |
| DOI: |
| 分类号: |
| 基金项目:中央引导地方科技发展资金项目S2025ZY01093 |
|
| Study on the Reaction Impurity Between Lomefloxacin and Excipient in Lomefloxacin Hydrochloride Ear Drops |
|
xu sen ao,zhou yu ping,zhou xia,zeng hong xia
|
|
1.China Jiliang University;2.Zhejiang Institute of Food and Drug Control
|
| Abstract: |
| ABSTRACT: OBJECTIVE To identify the structure of unknown impurity in lomefloxacin hydrochloride ear drops, analyze their formation mechanism, and establish a novel control method. METHODS The structure of unknown impurity was identified using liquid chromatography-ion trap-time-of-flight high-resolution mass spectrometry (LC/IT-TOF MS). Stability studies were conducted on products from six domestic manufacturers with different formulations and processes to investigate impurity formation mechanism. The developed analytical method was validated for impurity analysis. RESULTS The impurity was confirmed to result from the dehydration and condensation reaction between glycerol (an excipient in the formulation) and the C-N bond on the piperazine ring of lomefloxacin under elevated temperature condition. The newly developed HPLC method demonstrated strong specificity, as well as satisfactory precision, accuracy, linearity, and robustness. CONCLUSION This study provides guidance for controlling certain unknown impurity in pharmaceutical formulations and highlights the need for domestic manufacturers to address compatibility issues between active pharmaceutical ingredients (APIs) and excipients. |
| Key words: lomefloxacin hydrochloride impurity profiling unknown impurity LC/IT-TOF MS compatibility of raw-materials and excipients |